Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation1Minnie Sarwal, Oscar Salvatierra, Maria T. Millan et al.|Transplantation|2003Cited by 223